Association between genomic heterogeneity of hepatitis B virus and intrauterine infection

Virology

Volumn 387, Issue 1, 2009, Pages 168-175

  Cheng, Hai ^a   Su, Haixia ^a   Wang, Suping ^b   Shao, Zhongjun ^a   Men, Ke ^a   Li, Mingzheng ^c   Li, Shuzhen ^b   Zhang, Jingxia ^a   Xu, Jianqiu ^d   Zhang, Huiqin ^d   Yan, Yongping ^a   Xu, Dezhong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c Hangzhou Sanatorium of PLA   (China)

^d Shaanxi Maternal and Neonatal Health Hospital   (China)

Author keywords

Genomic heterogeneity; Hepatitis B virus; Intrauterine infection; Positive selection

Indexed keywords

EPITOPE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLONE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOMICS; HEPATITIS B VIRUS; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MALE; MOTHER; MOTHER FETUS RELATIONSHIP; MUTATION; NEWBORN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL;

ADULT; DNA, VIRAL; FEMALE; FETAL DISEASES; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 63549143826     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.02.015     Document Type: Article

References (56)

1. Arauz-Ruiz P., Norder H., Robertson B.H., and Magnius L.O. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J. Gen. Virol. 83 (2002) 2059-2073
2. Arimura C., Suzuki T., Yanagisawa M., Imamura M., Hamada Y., and Masaki T. Primary structure of chicken skeletal muscle and fibroblast alpha-actinins deduced from cDNA sequences. Eur. J. Biochem. 177 (1988) 649-655
3. Beasley R.P., Hwang L.Y., Lin C.C., Stevens C.E., Wang K.Y., Sun T.S., Hsieh F.J., and Szmuness W. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet 2 (1981) 388-393
4. Bichko V., Pushko P., Dreilina D., Pumpen P., and Gren E. Subtype ayw variant of hepatitis B virus. DNA primary structure analysis. FEBS Lett. 185 (1985) 208-212
5. Bock C.T., Malek N.P., Tillmann H.L., Manns M.P., and Trautwein C. The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro. J. Virol. 74 (2000) 2193-2202
6. Cavalli-Sforza L.L., and Edwards A.W. Phylogenetic analysis. Models and estimation procedures. Am. J. Hum. Genet. 19 (1967) 233-257
7. Chen I.H., Huang C.J., and Ting L.P. Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J. Virol. 69 (1995) 3647-3657
8. Cheng Y., Seet B.L., Ong C.S., Wasser S., Tan T.M., Peter F.J., and Lim S.G. Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?. Antiviral Res. 69 (2006) 142-151
9. del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W.C., Gerards L.J., de Gast G.C., Fetter W.P., Zwijneberg J., and Schalm S.W. Ten-year neonatal hepatitis B vaccination program, The Netherlands 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 15 (1997) 1624-1630
10. Fares M.A., and Holmes E.C. A revised evolutionary history of hepatitis B virus (HBV). J. Mol. Evol. 54 (2002) 807-814
11. Felsenstein J. PHYLIP: Phylogeny Inference Package, Ver. 3.572 (1995), University of Washington, Seattle, WA
12. Friedt M., Gerner P., Wintermeyer P., and Wirth S. Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis B. BMC Gastroenterol. 4 (2004) 11-19
13. Ganem D., and Prince A.M. Hepatitis B virus infection-natural history and clinical consequences. N. Engl. J. Med. 350 (2004) 1118-1129
14. Hannoun C., Horal P., and Lindh M. Long-term mutation rates in the hepatitis B virus genome. J. Gen. Virol. 81 (2000) 75-83
15. Higgins D.G., and Sharp P.M. CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 73 (1998) 237-244
16. Horikita M., Itoh S., Yamamoto K., Shibayama T., Tsuda F., and Okamoto H. Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. J. Med. Virol. 44 (1994) 96-103
17. Hou J., Liu Z., and Gu F. Epidemiology and prevention of hepatitis B virus infection. Int. J. Med. Sci. 2 (2005) 50-57
18. Hui C.K., and Lau G.K. Immune system and hepatitis B virus infection. J. Clin. Virol. 34 (2005) S44-48
19. Ip H.M., Lelie P.N., Wong V.C., Kuhns M.C., and Reesink H.W. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1 (1989) 406-410
20. Jung M.C., and Pape G.R. Immunology of hepatitis B infection. Lancet Infect. Dis. 2 (2002) 43-50
21. Kay A., and Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 127 (2007) 164-176
22. Kazim S.N., Wakil S.M., Khan L.A., Hasnain S.E., and Sarin S.K. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 359 (2002) 1488-1489
23. Kim K.T., Hyun S.W., Kim Y.S., and Rho H.M. Complete nucleotide sequence of hepatitis B virus (subtype adr). Korean J. Biochem. 21 (1988) 319-331
24. Kim J.H., Kang J.H., and Oh C.K. Immune responses and efficacy of hepatitis B vaccine in neonates born from hepatitis B carrier mothers: focus on HBV-DNA. Korean J. Pediatr. 41 (1998) 1498-1508
25. Kobayashi M., and Koike K. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization. Gene 30 (1984) 227-232
26. Kumar S., Tamura K., and Nei M. MEGA 3.1: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5 (2004) 150-163
27. Lee P.I., Lee C.Y., Huang L.M., and Chang M.H. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J. Pediatr. 126 (1995) 716-721
28. Li J., Buckwold V.E., Hon M.W., and Ou J.H. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J. Virol. 73 (1999) 1239-1244
29. Lopez-Cabrera M., Letovsky J., Hu K.Q., and Siddiqui A. Multiple liver specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5069-5073
30. Martin D.P., Williamson C., and Posada D. RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 21 (2005) 260-262
31. Maynard J.E., Kane M.A., and Hadler S.C. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev. Infect. Dis. 11 (1989) 574-578
32. Milich D., and Liang T.J. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38 (2003) 1075-1086
33. Milich D.R., Jones J.E., Hughes J.L., Price J., Raney A.K., and McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 6599-6603
34. Norder H., Courouce A.M., and Magnius L.O. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198 (1994) 489-503
35. Norder H., Courouce A.M., Coursaget P., Echevarria J.M., Lee S.D., Mushahwar I.K., Robertson B.H., Locarnini S., and Magnius L.O. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HB(s)Ag subtypes. Intervirology 47 (2004) 289-309
36. Okamoto H., Tsuda F., Sakugawa H., Sastrosoewignjo R.I., Imai M., Miyakawa Y., and Mayumi M. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol. 69 (1988) 2575-2583
37. Raney A.K., Johnson J.L., Palmer C.N., and McLachlan A. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J. Virol. 71 (1997) 1058-1071
38. Ren F., Tsubota A., Hirokawa T., Kumada H., Yang Z., and Tanaka H. A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Gene 383 (2006) 43-51
39. Renbao G., Meijin C., Lueping S., Suwen Q., and Zaiping L. The complete nucleotide sequence of the cloned DNA of hepatitis B virus subtype adr in pADR-1. Sci. Sin. 30 (1987) 507-521
40. Renner M., Haniel A., Bürgelt E., Hofschneider P.H., and Koch W. Transactivating function and expression of the x gene of hepatitis B virus. J. Hepatol. 23 (1995) 53-65
41. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4 (1987) 406-425
42. Stuyver L., De Gendt S., Van Geyt C., Zoulim F., Fried M., Schinazi R.F., and Rossau R. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J. Gen. Virol. 81 (2000) 67-74
43. Su H.X., Xu D.Z., Li D., Zhang J.X., Lu J., Choi B.C., and Yan Y.P. Heterogeneity analysis of the hepatitis B virus genome in intrauterine infection. J. Med. Virol. 77 (2005) 180-187
44. Takahashi K., Akahane Y., Hino K., Ohta Y., and Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch. Virol. 143 (1998) 2313-2326
45. Tong S. Mechanism of HBV genome variability and replication of HBV mutants. J. Clin. Virol. 34 (2005) S134-138
46. Tong S.P., Li J.S., Vitvitski L., and Trepo C. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. Virology 176 (1990) 596-603
47. Valenzuela P., Quiroga M., Zalvidar J., Gray P., and Rutter W.J. The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In: Fields B.N. (Ed). Animal Virus Genetics (1980), Academic Press, New York 57-70
48. Wang W.X., Li M., Wu X., Wang Y., and Li Z.P. HNF1 is critical for the liver-specific function of HBV enhancer II. Res. Virol. 149 (1998) 99-108
49. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J. Clin. Virol. 32 (2005) 102-112
50. Xie Y., Li M., Wang Y., Hofschneider P.H., and Weiss L. Site-specific mutation of the hepatitis B virus enhancer II B1 element: effect on virus transcription and replication. J. Gen. Virol. 82 (2001) 531-535
51. Xu D., Yan Y., and Xu J. A molecular epidemiology study on risk factors and mechanism of HBV intrauterine transmission. Zhonghua Yi Xue Za Zhi 79 (1999) 24-27
52. Xu D.Z., Yan Y.P., Choi B.C., Xu J.Q., Men K., Zhang J.X., Liu Z.H., and Wang F.S. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J. Med. Virol. 67 (2002) 20-26
53. Yang Z. PAML: a program package for phylogenetic analysis by maximum likelihood. Comput. Appl. Biosci. 13 (1997) 555-556
54. Yang Z. PAML4: a program package for phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24 (2007) 1586-1591
55. Yuh C.H., Chang Y.L., and Ting L.P. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. J. Virol. 66 (1992) 4073-4084
56. Zhang Z.G., Su H.X., Wu L., Yan Y.P., Men K., Zhang J.X., Wang A.H., Lu J., and Xu D.Z. A preliminary analysis between the mutation of the HBV preS/S gene and HBV intrauterine infection. Chin. J. Dis. Control Prev. 11 (2007) 1-4